One of three goals in AGU’s strategic plan is to lead in open science and open data; detailed guidelines, webinars, a help desk and data fair, aimed at AGU authors (but openly available to all), are designed to ensure that all scientific evidence is processed, shared, used ethically and fairly, and is available, preserved, and documented.
Arcadia Science is an R&D institute aspiring to evolve how science is done, who it attracts and rewards, and what it can achieve. Arcadia’s radical experiment in communication requires that all research must be freely accessible at an early stage and cannot be published in journals.
ASAP mandates OA for all publications of work that they fund, to facilitate the rapid and free exchange of scientific ideas and ensure that the research they fund to treat Parkinson’s disease can be leveraged for future discoveries.
Encouraging the use of preprints for research outputs beyond the scope of a traditional article and appearing well in advance of any associated eventual journal publication; drawing attention to non-traditional formats such as early stage results, null findings and replications of published works.
This toolkit includes templates, FAQs, documentation, and other items shared by COAPI members. Members share best practices in OA policy advocacy and implementation with each other by email, phone, and face-to-face meetings.
Crossref is an official digital object identifier (DOI) Registration Agency of the International DOI Foundation. It is run by the Publishers International Linking Association Inc. (PILA) and was launched in early 2000 as a cooperative effort among publishers to enable persistent cross-publisher citation linking in online academic journals.
This blogpost provides an overview of the specific ways that Crossref (along with organizations and initiatives like DataCite, ORCID, and ROR) helps U.S. federal agencies (and any other funder) meet critical aspects of the United States Office of Science and Technology Policy (OSTP) Nelson Memo’s recommendations.
Starting in 2023, eLife will no longer make accept/reject decisions but will publish all peer-reviewed papers on its website as Reviewed Preprints, including an eLife assessment and public reviews. Authors can respond and either revise/resubmit or declare it as the final Version of Record.
Gates-funded researchers can publish their original content, including detailed methods and all source data, on this platform. All content is open access under a CC-BY license; peer review is fully transparent, as are authors’ revisions and ongoing updates.
This policy is based on the belief that published research should be promptly and broadly disseminated. It enables the unrestricted access and reuse of all peer-reviewed published research funded, in whole or in part, by the Gates Foundation, including any underlying data sets.